购物车
- 全部删除
- 您的购物车当前为空
Eglumetad(又名LY354740)是由Eli Lilly and Company开发的研究性化合物,目前正被研究用于治疗焦虑症和化合物成瘾。这种化合物源于谷氨酸,其作用机制显示了一种新颖的机理。
Eglumetad(又名LY354740)是由Eli Lilly and Company开发的研究性化合物,目前正被研究用于治疗焦虑症和化合物成瘾。这种化合物源于谷氨酸,其作用机制显示了一种新颖的机理。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Eglumetad (also known as LY354740) is an investigational compound developed by Eli Lilly and Company, currently under research for the treatment of anxiety disorders and substance addiction. This compound originates from glutamate, demonstrating a novel mechanism of action. |
别名 | LY-354740, LY354740, LY 354740, Eglumetad, Eglumegad |
分子量 | 203.19 |
分子式 | C8H13NO5 |
CAS No. | 209216-09-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容